Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsBone Marrow PurgingBone and BonesCombined Modality TherapyCyclophosphamideCarmustineLymphoma, Non-HodgkinWhole-Body IrradiationMelphalanHematopoietic Stem CellsBone Marrow DiseasesAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationEtoposideHodgkin DiseaseColony-Forming Units AssayRemission InductionHematopoiesisLeukocytes, MononuclearTransplantation, HomologousLeukemia, Myeloid, AcuteBone RemodelingCytarabineTreatment OutcomeBone Marrow ExaminationBusulfanThiotepaBone TransplantationBone Marrow NeoplasmsDrug EvaluationRecurrenceTime FactorsCells, CulturedVincristineLeukemia, MyeloidLeukemiaTransplantation ConditioningFlow CytometryLeukocyte CountGranulocyte Colony-Stimulating FactorT-LymphocytesAntigens, CD34PodophyllotoxinBone DensityStem Cell TransplantationCell SeparationLymphomaMultiple MyelomaSalvage TherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaActuarial AnalysisGranulocytesSurvival AnalysisBlood Cell CountGranulocyte-Macrophage Colony-Stimulating FactorCell DifferentiationAntibodies, MonoclonalHematopoietic Stem Cell MobilizationBone ResorptionFollow-Up StudiesGraft vs Host DiseaseLymphocytesGraft SurvivalAntigens, CDImmunophenotypingBone NeoplasmsNeuroblastomaHematologic DiseasesPlatelet CountDisease-Free SurvivalBlood Transfusion, AutologousSurvival RateMice, Inbred C57BLDoxorubicinRecombinant ProteinsAcute DiseaseMesnaMitoxantronePrognosisStromal CellsB-LymphocytesBlood CellsBone RegenerationLymphatic IrradiationMyelodysplastic SyndromesPolymerase Chain ReactionThrombocytopeniaMonocytesNeutropeniaLymphocyte ActivationPrednisoneMesenchymal Stem Cell TransplantationProspective StudiesBone SubstitutesAgranulocytosisLomustineLymphoma, Follicular